Quick Answer
Merck & Co., Inc. reported Net Income Loss of $18.25 billion for the year ending 2025.
- Merck & Co., Inc. showed an increase of +6.6% in Net Income Loss from 2024 to 2025.
- This data is from Merck & Co., Inc.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 18 years of available data (2008 to 2025), Merck & Co., Inc.'s Net Income Loss has grown by 133.8%.
- Historical annual values: Fiscal year 2025: $18.25 billion | Fiscal year 2024: $17.12 billion | Fiscal year 2023: $365.00 million | Fiscal year 2022: $14.52 billion | Fiscal year 2021: $13.05 billion | Fiscal year 2020: $7.07 billion | Fiscal year 2019: $9.84 billion | Fiscal year 2018: $6.22 billion | Fiscal year 2017: $2.39 billion | Fiscal year 2016: $3.92 billion | Fiscal year 2015: $4.44 billion | Fiscal year 2014: $11.92 billion | Fiscal year 2013: $4.40 billion | Fiscal year 2012: $6.17 billion | Fiscal year 2011: $6.27 billion | Fiscal year 2010: $861.00 million | Fiscal year 2009: $12.90 billion | Fiscal year 2008: $7.81 billion.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: